Key Market Analysis of the Hong Kong Blood Typing, Grouping and Infectious Disease NAT Screening Market to 2024

DUBLIN, June 19, 2020 /PRNewswire/ -- The "2024 Hong Kong Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review" report has been added to's offering.

This report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report provides test volume and sales forecasts; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Competitive Assessments

    --  Strategic assessments of major suppliers and emerging market entrants,
        including their sales, M&A, product portfolios, marketing tactics, and
        new products in R&D.

Market Segmentation Analysis

    --  Test volume and sales forecasts for over 40 blood typing, grouping and
        infectious disease screening tests, including NAT.

Current and Emerging Products

    --  Analysis of current and emerging blood typing, grouping and infectious
        disease NAT screening assays.
    --  Review of automated and semi-automated molecular and immunohematology

Technology Review

    --  Assessment of current and emerging technologies, and their potential
        applications for the blood banking market.
    --  Comprehensive lists of companies developing or marketing new
        technologies and products, by test.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing


BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Strategic Recommendations

    --  New product development opportunities for blood typing, grouping and
        infectious disease NAT assays and instrumentation with significant
        market appeal.
    --  Alternative market penetration strategies.
    --  Potential market entry barriers and risks.

Companies Mentioned

    --  Abbott
    --  Beckman Coulter/Danaher
    --  Becton Dickinson
    --  Biokit
    --  BioMerieux
    --  Bio-Rad
    --  CellMark Forensics/LabCorp
    --  Diagast
    --  DiaSorin
    --  Fujirebio
    --  Grifols
    --  Hologic/Gen-Probe
    --  Immucor
    --  Ortho-Clinical Diagnostic
    --  Proteome Sciences
    --  Quest
    --  Quidel
    --  Roche
    --  Siemens
    --  Tecan
    --  Thermo Fisher

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets